The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study recently published. Men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer.
Continued use of low-dose aspirin may lower pancreatic cancer risk
Posted in Medical Research